Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
aMoon2 Fund
Ra’anana, Center District, Israel
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
aMoon Fund is Israel’s largest HealthTech investment fund ($1.1B AUM), investing in early/late-stage ventures pursuing solutions for high unmet medical needs. Recent investments include companies in AI-based diagnostics, autism therapies, cancer detection, and bio-interventional surgery—pipeline breadth is broad and diversified.
- Therapeutic areas
- OphthalmologyGastroenterologyOtherPsychiatryOncology
- Modalities
- Small moleculeBiologicDigital healthAI-enabled diagnosticsMedical device solutions
- Industry
- Investors
02
Partnerships
Roche (Ibex Medical Analytics for AI-enabled digital pathology)AWSMerck (M Ventures)BMC Innovation (ecosystem and academic partnerships)
Beyond the preview
Go deeper on aMoon2 Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on aMoon2 Fund.